Replies to post #372 on Clinuvel Pharmaceuticals (CLVLY)

[MinnieM]

Thanks for the interesting link... and, I'm especially thankful for google translate! ;)

I don't do well beyond very basic conversational German.







In Reply to 'FarmaZutical'
German analysis of Clinuvel's potential. Very well written and levelheaded. I still think, though, that the author sets the number of EPP patients far too low. I would also adjust the number of Vitiligo patient to reflect the 2-5 % prevalence in the US and the fact that Scenesse will target FP4-5. Still, the number of potential patients is a lot higher than what the author assumes. But I like his conservative approach and comprehensive analysis.

http://minussinus.de/clinuvel-unterbewertetes-pharmaunternehmen-startet-markteinfuehrung/